editor, reviewer
154
edits
Changes
| name = Haloperidol
| group = Butyrophenones
| type = Antipsychotic
| CAS = 52-86-8
| ChemSpiderID = 3438
| ATC = N05AD01
| pubchem = 3559
| half drugbank = APRD00538
| medscape = 8661
| emea drugscom = haloperidol | ftk = Haloperidolhaloperidol| type equivalent = Antipsychotic1| equivalent_ref = {{FTK-AP}}| comparison = haloperidol| avail = 60-70| avail_ref = <ref name="informatorium">{{KNMP|haloperidol}}</ref>| halflife = 17.5| halflife_ref = <ref name="pts">{{pts|3791}}</ref><ref name="informatorium" />| administration = O,IM,IV| dose = 0.25-15| dose_ref = <ref name="informatorium" />| DDD = 8| DDD_ref = <ref>{{WHOCC|N05AD01}}</ref>| ctox = 20| ctox_ref = {{FTK-AP}}| cth = 5| cth_ref = <ref name="pts" />
| <includeonly> isswitch=1</includeonly>
}}
